New
HealthMore in Health→
New Genomic Approach Reveals Hidden Genetic Risk in Rare Immune Cells
Key Takeaways
- Researchers have developed a new genomic approach to study long-range DNA interactions in rare immune cells, specifically ILC3s.
- The method overcomes the barrier of needing millions of cells, enabling study of disease-relevant rare cell types.
- The study, published in Nature Genetics, links distant DNA regions to genes in ILC3s, uncovering connections to autoimmune diseases like IBD.
- This breakthrough could lead to new therapeutic targets and a better understanding of disease mechanisms.
DE
DT Editorial Team··via medicalxpress.com